CD36 and atherosclerosis: Their activation is associated with a slowed progression of atherosclerosis through an inhibition of NF-κB activity, resulting in a decreased production of pro-inflammatory cytokines, as well as inhibited LDL uptake via a lowered expression of CD36 [130].